Clark Avery

• Healthcare executive with record of leading teams and complex initiatives to successful outcomes repeatedly
• Led business development for leading specialty pharmaceutical services company growing revenue and enterprise value significantly
• 15+ years leadership experience in specialty pharmaceuticals/biotech, reimbursement policy, and revenue cycle management; worked directly with providers, manufacturers, payers, and patients
• Led strategic planning function along with experience as healthcare strategy consultant

Companies

• Adjunct Professor California State University San Marcos (2018)
• Vice President, Bio-Pharmaceutical Sales Navigating Cancer (2016 — 2017)
• President/Co-Founder and Vice President, RCM Services Aesyntix Health (acquired by Modernizing Medicine) (2008 — 2015)
• General Manager Onmark, an OTN/McKesson Specialty Company (2005 — 2008)
• VP Business Development Oncology Therapeutics Network (OTN) (2003 — 2005)
• Director, Business Development Bristol-Myers Squibb/OTN (2001 — 2003)
• Business Development Veranto (2000 — 2001)
• Associate Consultant The Wilkerson Group (IBM Healthcare Consulting) (1998 — 2000)
• Student Yale School of Management (1996 — 1998)

Education

• California State University San Marcos (2017 — 2018)
• Master's in Public and Private Management (MPPM) Yale School of Management (1996.08 — 1998.05)
• BS California State University Long Beach (1985.09 — 1988.05)